Skip to main content

SPDR S&P Biotech ETF (XBI)

NYSEARCA: XBI · IEX Real-Time Price · USD
124.18 0.34 (0.27%)
Oct 22, 2021 4:00 PM EDT - Market closed
Expense Ratio0.35%
PE Ratio14.55
Shares Out54.28M
Dividend (ttm)$0.22
Dividend Yield0.17%
Ex-Dividend DateMar 22, 2021
1-Year Return
Previous Close123.84
Day's Range121.96 - 124.23
52-Week Low109.91
52-Week High174.74
Inception DateJan 31, 2006

About XBI

The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the S&P Biotechnology Select Industry Index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology segment of the S&P Total Market Index (S&P TMI).

Asset ClassEquity
RegionNorth America
IssuerState Street Global Advisors
Stock ExchangeNYSEARCA
Ticker SymbolXBI
Index TrackedS&P Biotechnology Select Industry Index

Top 10 Holdings

9.89% of assets
Acceleron PharmaXLRN1.01%
Kodiak SciencesKOD0.91%
Iovance BiotherapeuticsIOVA0.88%
Bluebird BioBLUE0.88%
ACADIA PharmaceuticalsACAD0.86%
Global Blood TherapeuticsGBT0.86%
View More Holdings


Ex-DividendAmountPay Date
Mar 22, 2021$0.040Mar 25, 2021
Dec 21, 2020$0.176Dec 24, 2020
Sep 21, 2020$0.08897Sep 24, 2020
Jun 22, 2020$0.01676Jun 25, 2020
Dec 20, 2019$0.00086Dec 26, 2019
Sep 20, 2019$0.00319Sep 25, 2019
Full Dividend History


Can Biotech ETFs Gain From Positive Booster Update?

In an effort to combat the coronavirus outbreak and accelerate the distribution process of extra doses in the United States, the FDA has approved the vaccine booster shots.

2 days ago - Zacks Investment Research

Is the biotech sell-off a buying opportunity

Jared Holz, Oppenheimer, on whether the dip in biotech is an opportunity for investors. With CNBC's Melissa Lee and the Fast Money traders, Guy Adami, Tim Seymour, Karen Finerman and Jeff Mills.

5 days ago - CNBC Television

MPM's Bardon on biotech investing outlook, $850 million oncology fund

Dr. Christiana Bardon, co-managing partner of MPM's BioImpact Capital, joins CNBC's 'Squawk Box' to discuss the public and private biotech investing landscape.

1 week ago - CNBC Television

ETFs All You Need For Portfolios

Building a core satellite ETF portfolio can give investors the best of two worlds.

4 weeks ago - ETFcom

Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 Years

It could perhaps deliver a much bigger gain than 100%.

1 month ago - The Motley Fool

Stocks to Correct 5-10% in 2021? Buy These ETFs

Some market watchers are raising concerns about overvaluation in the market. Investors can thus bet on these undervalued but top-ranked ETFs.

Other symbols:HEWJVYMXLB
1 month ago - Zacks Investment Research

5 Top ETFs With Great Value & More Room for Growth

The S&P 500 has been in a great shape this year, calling for overvaluation concerns. Why not investing in ETFs that have underperformed the S&P 500, have a lower P/E and have a Buy rating.

1 month ago - Zacks Investment Research

Best ETF Areas for Placing Your Bets in September

Let's take a look at some ETF areas that can be good investment options for September.

1 month ago - Zacks Investment Research

Top ETF Stories of August

Taper talks, the Senate approval of the infrastructure bill, upbeat earnings, FDA Approval for Pfizer COVID-19 Vaccine and recovery of China ETFs were the key highlights of the broader global markets in...

Other symbols:IFRAONLNSPYG
1 month ago - Zacks Investment Research

COVID Biotech ETFs Rise At Fever Pace

ETFs that look at a subsector of biotech have significantly outperformed broader biotech funds this year.

Other symbols:GERMIBBVIRS
1 month ago - ETFcom

Healthcare ETFs Surge on FDA Full-Vaccine Nod & Deal News

The FDA granted full approval of a COVID-19 vaccine made by Pfizer (PFE) and BioNTech that could accelerate inoculations in the United States.

1 month ago - Zacks Investment Research

Hopes of Moderna (MRNA) Vaccine Approval Boost Biotech

Biotech ETFs shot higher after the FDA formally approved Pfizer's vaccine. Trade the group's two largest funds with these tactical ideas.

Other symbols:IBB
2 months ago - Investopedia

Small-Cap Biotech Stocks Are Having a Rough Year, But That Could Change in a Heartbeat

While the world's leading biotech companies — churning out Covid-19 vaccines and treatments — have hit record share prices, their.

2 months ago - The Motley Fool

Biotech ETFs to Benefit From Latest Booster Update

The U.S. government's plans to make COVID-19 vaccine booster shots available from next month will likely increase the profits of vaccine makers.

2 months ago - Zacks Investment Research

How Are Biotech ETFs Reacting to These Q2 Earnings Releases?

Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.

2 months ago - Zacks Investment Research

3 Stocks to Buy for the Second Half of 2021

Even at all time high indices there are stocks to buy. Today we find three swing trade opportunities while the bulls are in charge.

Other symbols:EBAYNVAX
2 months ago - InvestorPlace

ETF Investing Areas to Consider for August

Let's take a look at some ETF areas that can be good investment options for August.

2 months ago - Zacks Investment Research

Delta Variant Surge Brings Biotech ETFs in Focus

The biotech sector seems like a lucrative investment space as the delta variant of coronavirus continues to spread.

2 months ago - Zacks Investment Research

9 Best Biotech ETFs to Play High-Octane Trends

Biotechnology is a dynamic but often volatile industry. These biotech ETFs provide a lower-risk way to invest in the space.

3 months ago - Kiplinger

IBB Vs. XBI: Which Biotech ETF Has A Better Chart?

The SPDR S&P Biotech ETF (NYSE: XBI) is trading below an important resistance level, but the iShares Nasdaq Biotechnology ETF (NASDAQ: IBB) has broken out. Resistance is a large group of sellers who are...

Other symbols:IBB
3 months ago - Benzinga

Should You Buy Biotech ETFs Now?

Biotech stocks are rallying this month; can the trend continue?

4 months ago - Zacks Investment Research

3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort

In a sector where picking individual stocks is a high-risk, high-reward strategy, the diversification of exchange-traded funds can be highly appealing.

Other symbols:GNOMINDA
4 months ago - The Motley Fool

Biotech ETFs Surge on Biogen's Alzheimer Drug Approval

The approval for Biogen's Alzheimer's disease treatment has spread strong optimism, with many investors pulling in capital to this high growth and high beta sector.

4 months ago - Zacks Investment Research

3 Top Stock Trades for the Week

These three ETFs were red-hot on Monday, making them obvious choices for this week's top stock trades. Here's how to play them with options.

Other symbols:IWMMJ
4 months ago - InvestorPlace

7 Best Equal-Weight ETFs To Buy In June

Financial planners highlight the benefits of ETFs track an equal-weighted index. Here are seven of the leading ETFs to consider in June.

4 months ago - InvestorPlace